Krueger Christopher W 4
4 · Ventyx Biosciences, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Krueger Christopher W
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02+125,000→ 125,000 totalExercise: $2.49Exp: 2034-01-02→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]100% of the total shares subject to the Option shall vest on the one-year anniversary of January 2, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through such date.